ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $21.10 +0.21 (+1.01%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$21.11 +0.01 (+0.05%) As of 07/2/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Stock Price Performance The ArriVent BioPharma (AVBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 15.49%, with a year-to-date return of -20.80%. In the past month, the stock has decreased 8.74%, reflecting recent market activity. As of the latest close, ArriVent BioPharma traded at $21.10 with a market cap of $721.83 million and volume of 949,102 shares. Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.90%1 Month Performance-8.74%3 Month Performance+24.56%Year-To-Date Performance-20.80%1 Year Performance+15.49% AVBP Stock Chart for Thursday, July, 3, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$20.89$21.10+1.01%$21.89$20.00949,102 shs$721.83 million07/01/2025$21.77$20.89-4.04%$22.07$20.68415,115 shs$714.65 million06/30/2025$22.91$21.77-4.98%$23.17$21.68297,630 shs$744.75 million06/27/2025$22.81$22.91+0.44%$23.26$22.31876,062 shs$783.75 million06/26/2025$22.80$22.81+0.04%$23.05$22.12284,039 shs$780.33 million06/25/2025$23.11$22.80-1.34%$23.44$22.53418,097 shs$780.06 million06/24/2025$22.80$23.11+1.36%$24.03$22.71928,851 shs$790.59 million06/23/2025$25.22$22.80-9.60%$25.73$22.041.35 million shs$779.99 million06/20/2025$24.89$25.22+1.33%$25.58$24.55441,501 shs$862.85 million06/19/2025$24.89$24.89$25.63$24.61221,896 shs$851.49 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$24.98$24.89-0.36%$25.63$24.61221,896 shs$851.49 million06/17/2025$25.42$24.98-1.73%$25.80$24.06347,325 shs$854.64 million06/16/2025$23.27$25.42+9.24%$25.57$22.97512,100 shs$869.69 million06/13/2025$23.63$23.27-1.52%$23.93$22.92441,320 shs$796.14 million06/12/2025$23.28$23.63+1.50%$23.64$22.65672,635 shs$808.45 million06/11/2025$24.50$23.28-4.98%$25.07$23.20179,002 shs$796.48 million06/10/2025$23.60$24.50+3.81%$24.75$23.76322,545 shs$838.22 million06/09/2025$23.52$23.60+0.34%$24.05$23.20199,839 shs$807.43 million06/06/2025$23.47$23.52+0.21%$23.91$23.19219,200 shs$804.69 million06/05/2025$22.72$23.47+3.30%$24.05$22.50529,702 shs$802.98 million06/04/2025$23.12$22.72-1.73%$23.77$22.66386,063 shs$777.32 million06/03/2025$22.00$23.12+5.09%$23.55$21.93569,421 shs$791.01 million06/02/2025$21.20$22.00+3.77%$22.42$21.01588,332 shs$752.69 million Related Companies Kymera Therapeutics Stock Chart Metsera Stock Chart Crinetics Pharmaceuticals Stock Chart Viking Therapeutics Stock Chart MoonLake Immunotherapeutics Stock Chart MorphoSys Stock Chart Alvotech Stock Chart HUTCHMED Stock Chart Immunovant Stock Chart Catalyst Pharmaceuticals Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts